Correction to: Neuropsychopharmacology 10.1038/s41386-022-01359-5, published online 18 June 2022
In this article the GFAP was measured in plasma, not serum. GFAP can be measured in either serum or plasma, but all samples in this study were measured in plasma. The article was corrected accordingly.
The title was corrected accordingly from “Association of day-of-injury serum glial fibrillary acidic protein concentration and six-month posttraumatic stress disorder in patients with mild traumatic brain injury” to “Association of day-of-injury plasma glial fibrillary acidic protein concentration and six-month posttraumatic stress disorder in patients with mild traumatic brain injury”.
None of the data change as a result of this clarification.
None of the scientific conclusions of the paper are affected.
The original article has been corrected.
Footnotes
The original article can be found online at 10.1038/s41386-022-01359-5.
A list of authors and their affiliations appears online.
Contributor Information
Murray B. Stein, Email: mstein@health.ucsd.edu
TRACK-TBI Investigators:
Neeraj Badjatia, Ann-Christine Duhaime, V. Ramana Feeser, C. Dirk Keene, Christopher Madden, Randall Merchant, Ava Puccio, David Schnyer, Sabrina R. Taylor, Alex Valadka, John K. Yue, Esther L. Yuh, and Ross Zafonte